Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

IMPORTANCE: Phase 1 cancer studies, which guide dose selection for subsequent studies, are almost 3 times more prevalent than phase 3 studies and have a median study duration considerably longer than 2 years, which constitutes a major component of drug development time. OBJECTIVE: To discern a metho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Netw Open
Autors principals: Frankel, Paul H., Chung, Vincent, Tuscano, Joseph, Siddiqi, Tanya, Sampath, Sagus, Longmate, Jeffrey, Groshen, Susan, Newman, Edward M.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7221509/
https://ncbi.nlm.nih.gov/pubmed/32401317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.4787
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars